Stephanie J. Simmerman, ARNP

Stephanie Simmerman practices at Gardens Plastic Surgery in Cape Coral, Florida.

Stephanie Simmerman's NPI, 1871844175, was assigned on September 26, 2012. Stephanie Simmerman graduated from University of Florida College of Medicine in 2012. Stephanie Simmerman holds Florida license ARNP9266200.

Stephanie Simmerman's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Stephanie Simmerman's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Stephanie Simmerman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Simmerman practices. Vendor and product names are available with a free account.

Nurse practitioner is Stephanie Simmerman's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Stephanie Simmerman is licensed in Florida.

Dmand AI lists acne, acute skin infection, ankle or foot injury, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, eyelid inflammation and facial skin infection among the conditions Stephanie Simmerman treats.

CMS data shows 7,041 Medicare services from Stephanie Simmerman across 24 procedure codes in 2024, for 1,000 Medicare patients. Medicare paid $279,702 for them. Every service was in an office.

CMS counts 1,000 Medicare patients who saw Stephanie Simmerman in 2024. The largest group is 75 to 84, with 446 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Stephanie Simmerman's median patient age at 74, with 57% women.

In 2024, Stephanie Simmerman wrote 1,167 Medicare Part D claims for 504 patients. 89% of them were for generic drugs. CMS names the drug for 984 of them, across 18 drugs with 11 or more claims each, at $569,270 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Stephanie Simmerman for performance year 2024, reported as part of a group. Stephanie Simmerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 508 general payments to Stephanie Simmerman from 22 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Dermavant Sciences, Inc. paid the most, $37,576.

Stephanie Simmerman graduated from University of Florida College of Medicine in 2012.